Adult Stem Cell Therapy for Stroke: Challenges and Progress

키워드

참고문헌 (113)

1. Dihné M, "Restoring neuronal function after stroke by cell replacement : anatomic and functional considerations", Stroke, 42, pp.2342~2350 (2011)
2. Rosenblum S, "Timing of intra-arterial neural stem cell transplantation after hypoxia-ischemia influences cell engraftment, survival, and differentiation", Stroke, 43, pp.1624~1631 (2012)
3. Chen X, "Ischemic rat brain extracts induce human marrow stromal cell growth factor production", Neuropathology, 22, pp.275~279 (2002)
4. Li WY, "Mesenchymal stem cells for ischemic stroke : changes in effects after ex vivo culturing", Cell Transplant, 17, pp.1045~1059 (2008)
5. Liu Z, "Bone marrow stromal cells promote skilled motor recovery and enhance contralesional axonal connections after ischemic stroke in adult mice", Stroke, 42, pp.740~744 (2011)
6. Song M, "Restoration of intracortical and thalamocortical circuits after transplantation of bone marrow mesenchymal stem cells into the ischemic brain of mice", Cell Transplant, 22, pp.2001~2015 (2013)
7. Lai RC, "Mesenchymal stem cell exosome : a novel stem cell-based therapy for cardiovascular disease", Regen Med, 6, pp.481~492 (2011)
8. Kim YJ, "Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti-inflammatory action", Glia, 57, pp.13~23 (2009)
9. Acosta SA, "Intravenous bone marrow stem cell grafts preferentially migrate to spleen and abrogate chronic inflammation in stroke", Stroke, 46, pp.2616~2627 (2015)
10. Shen LH, "Therapeutic benefit of bone marrow stromal cells administered 1 month after stroke", J Cereb Blood Flow Metab, 27, pp.6~13 (2007)
11. Shin JY, "Mesenchymal stem cells enhance autophagy and increase beta-amyloid clearance in Alzheimer disease models", Autophagy, 10, pp.32~44 (2014)
12. Paik MJ, "The free fatty acid metabolome in cerebral ischemia following human mesenchymal stem cell transplantation in rats", Clin Chim Acta, 402, pp.25~30 (2009)
13. Yamauchi T, "Therapeutic effects of human multilineage-differentiating stress enduring (MUSE) cell transplantation into infarct brain of mice", PLoS ONE, 10, pp.e0116009~ (2015)
14. Bang OY, "Autologous mesenchymal stem cell transplantation in stroke patients", Ann Neurol, 57, pp.874~882 (2005)
15. Lee JS, "A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke", Stem Cells, 28, pp.1099~1106 (2010)
16. Honmou O, "Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke", Brain, 134(Pt 6), pp.1790~1807 (2011)
17. Bhasin A, "Autologous mesenchymal stem cells in chronic stroke", Cerebrovasc Dis Extra, 1, pp.93~104 (2011)
18. Hess DC, "Final results of the B01-02 phase 2 trial testing the safety and efficacy of MultiStem® in treatment of ischemic stroke", International Stroke Conference (2016)
19. Suárez-Monteagudo C, "Autologous bone marrow stem cell neurotransplantation in stroke patients. An open study", Restor Neurol Neurosci, 27, pp.151~161 (2009)
20. Battistella V, "Safety of autologous bone marrow mononuclear cell transplantation in patients with nonacute ischemic stroke", Regen Med, 6, pp.45~52 (2011)
21. Savitz SI, "Intravenous autologous bone marrow mononuclear cells for ischemic stroke", Ann Neurol, 70, pp.59~69 (2011)
22. Friedrich MA, "Intra-arterial infusion of autologous bone marrow mononuclear cells in patients with moderate to severe middle cerebral artery acute ischemic stroke", Cell Transplant, 21(Suppl 1), pp.S13~S21 (2012)
23. Li ZM, "Autologous bone marrow mononuclear cell implantation for intracerebral hemorrhage-a prospective clinical observation", Clin Neurol Neurosurg, 115, pp.72~76 (2013)
24. Prasad K, "Intravenous autologous bone marrow mononuclear stem cell therapy for ischemic stroke: a multicentric, randomized trial", Stroke, 45, pp.3618~3624 (2014)
25. 방오영, "Clinical Trials of Adult Stem Cell Terapy in Patients with Ischemic Stroke", Journal of Clinical Neurology, 12(1), pp.14~20 (2016), 대한신경과학회[DOI]
26. Lees JS, "Stem cell-based therapy for experimental stroke : a systematic review and meta-analysis", Int J Stroke, 7, pp.582~588 (2012)
27. Golpanian S, "Concise review : review and perspective of cell dosage and routes of administration from preclinical and clinical studies of stem cell therapy for heart disease", Stem Cells Transl Med, 5, pp.186~191 (2016)
28. Caplan AI, "Why are MSCs therapeutic? New data : new insight", J Pathol, 217, pp.318~324 (2009)
29. Bonab MM, "Aging of mesenchymal stem cell in vitro", BMC Cell Biol, 7, pp.14~ (2006)
30. Rombouts WJ, "Primary murine MSC show highly efficient homing to the bone marrow but lose homing ability following culture", Leukemia, 17, pp.160~170 (2003)
31. Hill WD, "SDF-1(CXCL12)is upregulated in the ischemic penumbra following stroke : association with bone marrow cell homing to injury", J Neuropathol Exp Neurol, 63, pp.84~96 (2004)
32. Savitz SI, "Developing cellular therapies for stroke", Stroke, 46, pp.2026~2031 (2015)
33. Manganas LN, "Magnetic resonance spectroscopy identifies neural progenitor cells in the live human brain", Science, 318, pp.980~985 (2007)
34. Watson N, "No pain, no gain: lack of exercise obstructs neurogenesis", Cell Transplant, 24, pp.591~597 (2015)
35. Jin K, "Evidence for stroke-induced neurogenesis in the human brain", Proc Natl Acad Sci U S A, 103, pp.13198~13202 (2006)
36. Darsalia V, "Stroke-induced neurogenesis in aged brain", Stroke, 36, pp.1790~1795 (2005)
37. Piccin D, "Neural stem and progenitor cells in the aged subependyma are activated by the young niche", Neurobiol Aging, 35, pp.1669~1679 (2014)
38. Choumerianou DM, "Comparative study of stemness characteristics of mesenchymal cells from bone marrow of children and adults", Cytotherapy, 12, pp.881~887 (2010)
39. Asumda FZ, "Age-related changes in rat bone-marrow mesenchymal stem cell plasticity", BMC Cell Biol, 12, pp.44~ (2011)
40. Oh J, "Stem cell aging: mechanisms, regulators and therapeutic opportunities", Nat Med, 20, pp.870~880 (2014)
41. Brohlin M, "Aging effect on neurotrophic activity of human mesenchymal stem cells", PLoS ONE, 7, pp.e45052~ (2012)
42. Chen J, "Adverse effects of bone marrow stromal cell treatment of stroke in diabetic rats", Stroke, 42, pp.3551~3558 (2011)
43. Popa-Wagner A, "Stem cell therapies in preclinical models of stroke associated with aging", Front Cell Neurosci, 8, pp.347~ (2014)
44. Kawai H, "Tridermal tumorigenesis of induced pluripotent stem cells transplanted in ischemic brain", J Cereb Blood Flow Metab, 30, pp.1487~1493 (2010)
45. Chen J, "Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats", Stroke, 32, pp.1005~1011 (2001)
46. Pendharkar AV, "Biodistribution of neural stem cells after intravascular therapy for hypoxic-ischemia", Stroke, 41, pp.2064~2070 (2010)
47. Ikegame Y, "Comparison of mesenchymal stem cells from adipose tissue and bone marrow for ischemic stroke therapy", Cytotherapy, 13, pp.675~685 (2011)
48. Chan TM, "The use of ADSCs as a treatment for chronic stroke", Cell Transplant, 23, pp.541~547 (2014)
49. Lin YC, "Human umbilical mesenchymal stem cells promote recovery after ischemic stroke", Stroke, 42, pp.2045~2053 (2011)
50. Hsieh JY, "Mesenchymal stem cells from human umbilical cord express preferentially secreted factors related to neuroprotection, neurogenesis, and angiogenesis", PLoS ONE, 8, pp.e72604~ (2013)
51. Nakanishi C, "Gene and protein expression analysis of mesenchymal stem cells derived from rat adipose tissue and bone marrow", Circ J, 75, pp.2260~2268 (2011)
52. Szöke K, "Human adipose tissue as a source of cells with angiogenic potential", Cell Transplant, 21, pp.235~250 (2012)
53. Zhang L, "Delayed administration of human umbilical tissue-derived cells improved neurological functional recovery in a rodent model of focal ischemia", Stroke, 42, pp.1437~1444 (2011)
54. Li Y, "Mesenchymal stem cells are injured by complement after their contact with serum", Blood, 120, pp.3436~3443 (2012)
55. Zakrzewski JL, "Overcoming immunological barriers in regenerative medicine", Nat Biotechnol, 32, pp.786~794 (2014)
56. Zacharek A, "Comparison of bone marrow stromal cells derived from stroke and normal rats for stroke treatment", Stroke, 41, pp.524~530 (2010)
57. Yang B, "Intra-arterial delivery is not superior to intravenous delivery of autologous bone marrow mononuclear cells in acute ischemic stroke", Stroke, 44, pp.3463~3472 (2013)
58. Wei N, "Delayed intranasal delivery of hypoxic-preconditioned bone marrow mesenchymal stem cells enhanced cell homing and therapeutic benefits after ischemic stroke in mice", Cell Transplant, 22, pp.977~991 (2013)
59. Wei ZZ, "Intranasal delivery of bone marrow mesenchymal stem cells improved neurovascular regeneration and rescued neuropsychiatric deficits after neonatal stroke in rats", Cell Transplant, 24, pp.391~402 (2015)
60. Borlongan CV, "Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke", Stroke, 35, pp.2385~2389 (2004)
61. Kim SJ, "Intravenous transplantation of mesenchymal stem cells preconditioned with early phase stroke serum: current evidence and study protocol for a randomized trial", Trials, 14, pp.317~ (2013)
62. Efimenko A, "Autologous stem cell therapy : how aging and chronic diseases affect stem and progenitor cells", BioRes Open Access, 4, pp.26~38 (2015)
63. Griffiths S, "Human platelet lysate stimulates high-passage and senescent human multipotent mesenchymal stromal cell growth and rejuvenation in vitro", Cytotherapy, 15, pp.1469~1483 (2013)
64. Bang OY, "Preconditioning and rejuvenation of mesenchymal stem cells using serum obtained at the acute phase of stroke: preclinical data of the STARTING-2 trial", 24th European Stroke Conference (2015)
65. Hu X, "Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis", J Thorac Cardiovasc Surg, 135, pp.799~808 (2008)
66. Liu H, "The role of SDF-1-CXCR4", CXCR7 axis in the therapeutic effects of hypoxia-preconditioned mesenchymal stem cells for renal ischemia, PLoS ONE, pp.2012, 7[DOI]
67. Liu H, "Hypoxic preconditioning advances CXCR4 and CXCR7 expression by activating HIF-1alpha in MSCs", Biochem Biophys Res Commun, 401, pp.509~515 (2010)
68. Pasha Z, "Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium", Cardiovasc Res, 77, pp.134~142 (2008)
69. Tang YL, "Hypoxic preconditioning enhances the benefit of cardiac progenitor cell therapy for treatment of myocardial infarction by inducing CXCR4 expression", Circ Res, 104, pp.1209~1216 (2009)
70. Choi YJ, "Enhancing trophic support of mesenchymal stem cells by ex vivo treatment with trophic factors", J Neurol Sci, 298, pp.28~34 (2010)
71. Rani S, "Mesenchymal stem cell-derived extracellular vesicles : toward cell-free therapeutic applications", Mol Ther, 23, pp.812~823 (2015)
72. Kurozumi K, "Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model", Mol Ther, 11, pp.96~104 (2005)
73. Kurozumi K, "BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model", Mol Ther, 9, pp.189~197 (2004)
74. Nomura T, "infusion of brain-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat", Neuroscience, 136, pp.161~169 (2005)
75. Bang OY, "The effect of CXCR4 overexpression on mesenchymal stem cell transplantation in ischemic stroke", Cell Med, 4, pp.65~76 (2012)
76. Kim SJ, "Circulating mesenchymal stem cells microparticles in patients with cerebrovascular disease", PLoS ONE, 7, pp.e37036~ (2012)
77. Lai RC, "Proteolytic potential of the MSC exosome proteome : implications for an exosome-mediated delivery of therapeutic proteasome", Int J Proteomics, 2012, pp.971907~ (2012)
78. Sun D, "A novel nanoparticle drug delivery system : the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes", Mol Ther, 18, pp.1606~1614 (2010)
79. Zhuang X, "Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain", Mol Ther, 19, pp.1769~1779 (2011)
80. Raisi A, "The mesenchymal stem cell-derived microvesicles enhance sciatic nerve regeneration in rat : a novel approach in peripheral nerve cell therapy", J Trauma Acute Care Surg, 76, pp.991~997 (2014)
81. Taylor AR, "Regulation of heat shock protein 70 release in astrocytes : role of signaling kinases", Dev Neurobiol, 67, pp.1815~1829 (2007)
82. Xin H, "Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity after stroke in rats", J Cereb Blood Flow Metab, 33, pp.1711~1715 (2013)
83. Moon GJ, "Mesenchymal stem cell-derived microvesicle therapy for stroke : neurogenic", angiogenic effects and biodistribution in a rat stroke model, 2015, ~
84. Yu DC, "Circulating microRNAs : potential biomarkers for cancer", Int J Mol Sci, 12, pp.2055~2063 (2011)
85. Caballero-Garrido E, "In vivo inhibition of miR-155 promotes recovery after experimental mouse stroke", J Neurosci, 35, pp.12446~12464 (2015)
86. Juranek JK, "RAGE deficiency improves postinjury sciatic nerve regeneration in type 1 diabetic mice", Diabetes, 62, pp.931~943 (2013)
87. Xin H, "Exosome-mediated transfer of miR-133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth", Stem Cells, 30, pp.1556~1564 (2012)
88. Bhalala OG, "The emerging roles of microRNAs in CNS injuries", Nat Rev Neurol, 9, pp.328~339 (2013)
89. Huang F, "Mesenchymal stem cells modified with miR-126 release angiogenic factors and activate Notch ligand Delta-like-4, enhancing ischemic angiogenesis and cell survival", Int J Mol Med, 31, pp.484~492 (2013)
90. Yang J, "Buyang Huanwu decoction(BYHWD)enhances angiogenic effect of mesenchymal stem cell by upregulating VEGF expression after focal cerebral ischemia", J Mol Neurosci, 56, pp.898~906 (2015)
91. Kim EH, "Stroke serum priming modulates characteristics of mesenchymal stromal cells by controlling the expression miRNA-20a", Cell Transplant, 25, pp.1489~1499 (2016)
92. Lane SW, "Modulating the stem cell niche for tissue regeneration", Nat Biotechnol, 32, pp.795~803 (2014)
93. Li W, "Chemical approaches to stem cell biology and therapeutics", Cell Stem Cell, 13, pp.270~283 (2013)
94. Sart S, "Three-dimensional aggregates of mesenchymal stem cells: cellular mechanisms, biological properties, and applications", Tissue Eng Part B Rev, 20, pp.365~380 (2014)
95. Galipeau J, "The mesenchymal stromal cells dilemma--does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road?", Cytotherapy, 15, pp.2~8 (2013)
96. Bartosh TJ, "Aggregation of human mesenchymal stromal cells(MSCs)into 3D spheroids enhances their antiinflammatory properties", Proc Natl Acad Sci U S A, 107, pp.13724~13729 (2010)
97. Frith JE, "Dynamic three-dimensional culture methods enhance mesenchymal stem cell properties and increase therapeutic potential", Tissue Eng Part C Methods, 16, pp.735~749 (2010)
98. Langenbach F, "Generation and differentiation of microtissues from multipotent precursor cells for use in tissue engineering", Nat Protoc, 6, pp.1726~1735 (2011)
99. Miyagawa Y, "A microfabricated scaffold induces the spheroid formation of human bone marrow-derived mesenchymal progenitor cells and promotes efficient adipogenic differentiation", Tissue Eng Part A, 17, pp.513~521 (2011)
100. Zimmermann JA, "Pre-conditioning mesenchymal stromal cell spheroids for immunomodulatory paracrine factor secretion", Cytotherapy, 16, pp.331~345 (2014)
101. Bensaïd W, "A biodegradable fibrin scaffold for mesenchymal stem cell transplantation", Biomaterials, 24, pp.2497~2502 (2003)
102. Wang J, "Ischemic stroke and repair : current trends in research and tissue engineering treatments", Regen Med Res, 2, pp.3~ (2014)
103. George P, "Abstract T MP17: Electrically preconditioned neural stem cells improve stroke recovery", Stroke, 46, pp.ATMP17~ATMP17 (2015)
104. Li RK, "Construction of a bioengineered cardiac graft", J Thorac Cardiovasc Surg, 119, pp.368~375 (2000)
105. Zimmermann WH, "Tissue engineering of a differentiated cardiac muscle construct", Circ Res, 90, pp.223~230 (2002)
106. Cameron CM, "Improved development of human embryonic stem cell-derived embryoid bodies by stirred vessel cultivation", Biotechnol Bioeng, 94, pp.938~948 (2006)
107. Fok EY, "Shear-controlled single-step mouse embryonic stem cell expansion and embryoid body-based differentiation", Stem Cells, 23, pp.1333~1342 (2005)
108. Kehoe DE, "Propagation of embryonic stem cells in stirred suspension without serum", Biotechnol Prog, 24, pp.1342~1352 (2008)
109. Niebruegge S, "Generation of human embryonic stem cell-derived mesoderm and cardiac cells using size-specified aggregates in an oxygen-controlled bioreactor", Biotechnol Bioeng, 102, pp.493~507 (2009)
110. Niebruegge S, "Cardiomyocyte production in mass suspension culture : embryonic stem cells as a source for great amounts of functional cardiomyocytes", Tissue Eng Part A, 14, pp.1591~1601 (2008)
111. Schroeder M, "Differentiation and lineage selection of mouse embryonic stem cells in a stirred bench scale bioreactor with automated process control", Biotechnol Bioeng, 92, pp.920~933 (2005)
112. Aref A, "Optical monitoring of stem cell-substratum interactions", J Biomed Opt, 14(1), pp.010501~ (2009)
113. Kirouac DC, "The systematic production of cells for cell therapies", Cell Stem Cell, 3, pp.369~381 (2008)

관련 논문AI추천